Billionaires Holding OGXI

BILLIONAIRE ALLOCATION SHARES OWNED (M) % CO AVG. COST RETURN

FUNDAMENTALS

  • N/A
    PE

  • 0.0
    Yield

  • 21.3M
    Shares Outstanding

  • 15.31M
    Market Cap

News & Insights

ABOUT

OGXI

OncoGenex Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapies that address treatment resistance in cancer patients. Its lead drug candidate, Custirsen is in Phase III clinical development for the treatment in men with metastatic castrate-resistant prostate ca...

Procter & Gamble Co.'s Worst Moves in 2016

NEWS

US STOCKS-Wall St set to open flat as investors test rally

READ MORE